Breast Cancer Specification
0.1.0 - ci-build
Breast Cancer Specification - Local Development build (v0.1.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
This example follows the ICCR-oriented model, where the sentinel lymph node biopsy is reported as a standalone document. In German clinical practice, the SLN report is usually integrated into the breast specimen report under a single accession number (see Clinical Context — Lymph node reporting for details on both approaches). An integrated report example combining both breast and lymph node findings is available under Integrated Report (BET + SLN).
The sentinel lymph node biopsy specimen comprises 7 specimen instances in a three-level hierarchy: part → paraffin blocks → slides. No immunohistochemistry is performed on the lymph node specimen (biomarkers are determined on the primary tumour).
| Instance | Description |
|---|---|
| LymphNodeSpecimenPart | Sentinel lymph node excision specimen, left axilla, 2 SLN identified (patent blue dye), fully embedded |
| Instance | Description |
|---|---|
| LymphNodeSpecimenBlock01 | SLN #1, bisected — contains micrometastasis (1.2 mm) |
| LymphNodeSpecimenBlock02 | SLN #2, bisected — tumour-free |
| Instance | Description |
|---|---|
| LymphNodeSpecimenSlideHE01 | H&E slide, SLN #1, section level 1 |
| LymphNodeSpecimenSlideHE02 | H&E slide, SLN #1, section level 2 |
| Instance | Description |
|---|---|
| LymphNodeSpecimenSlideHE03 | H&E slide, SLN #2, section level 1 |
| LymphNodeSpecimenSlideHE04 | H&E slide, SLN #2, section level 2 |